Phase 1 volunteer infection study of Ruxolitinib to boost immunity to malaria parasites
Thank you for your interest. For more information, click here.
QIMR-HREC Approval Reference: P3696
Open Date: July 2021
Recruitment Status: OPEN
STUDY CONTACT DETAILS
A: USC Clinical Trials Centre and QIMR Berghofer Medical Research Institute
300 Herston Road
Herston, QLD, 4006, AUSTRALIA